Showing results 5 to 12 of 12
< previous
| Issue Date | Title | Author(s) |
| 2015-05 | Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. | Essilfie, A-T; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Beckett, EL; Starkey, MR; Simpson, JL; Foster, PS; Gibson, PG; Hansbro, PM |
| 2017-07-01 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma | Hansbro, PM; Kim, RY; Starkey, MR; Donovan, C; Dua, K; Mayall, JR; Liu, G; Hansbro, NG; Simpson, JL; Wood, LG; Hirota, JA; Knight, DA; Foster, PS; Horvat, JC |
| 2017-02-01 | MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2 | Kim, RY; Horvat, JC; Pinkerton, JW; Starkey, MR; Essilfie, AT; Mayall, JR; Nair, PM; Hansbro, NG; Jones, B; Haw, TJ; Sunkara, KP; Nguyen, TH; Jarnicki, AG; Keely, S; Mattes, J; Adcock, IM; Foster, PS; Hansbro, PM |
| 2021-10-19 | Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. | Pinkerton, JW; Kim, RY; Brown, AC; Rae, BE; Donovan, C; Mayall, JR; Carroll, OR; Khadem Ali, M; Scott, HA; Berthon, BS; Baines, KJ; Starkey, MR; Kermani, NZ; Guo, Y-K; Robertson, AAB; O'Neill, LAJ; Adcock, IM; Cooper, MA; Gibson, PG; Wood, LG; Hansbro, PM; Horvat, JC |
| 2017-08-01 | Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma | Kim, RY; Pinkerton, JW; Essilfie, AT; Robertson, AAB; Baines, KJ; Brown, AC; Mayall, JR; Ali, MK; Starkey, MR; Hansbro, NG; Hirota, JA; Wood, LG; Simpson, JL; Knight, DA; Wark, PA; Gibson, PG; O'Neill, LAJ; Cooper, MA; Horvat, JC; Hansbro, PM |
| 2017-07-01 | Role of iron in the pathogenesis of respiratory disease | Ali, MK; Kim, RY; Karim, R; Mayall, JR; Martin, KL; Shahandeh, A; Abbasian, F; Starkey, MR; Loustaud-Ratti, V; Johnstone, D; Milward, EA; Hansbro, PM; Horvat, JC |
| 2020-10-01 | SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro | Hsu, AC-Y; Wang, G; Reid, AT; Veerati, PC; Pathinayake, PS; Daly, K; Mayall, JR; Hansbro, PM; Horvat, JC; Wang, F; Wark, PA |
| 2021-06-03 | T-helper 22 cells develop as a distinct lineage from Th17 cells during bacterial infection and phenotypic stability is regulated by T-bet. | Barnes, JL; Plank, MW; Asquith, K; Maltby, S; Sabino, LR; Kaiko, GE; Lochrin, A; Horvat, JC; Mayall, JR; Kim, RY; Hansbro, PM; Keely, S; Belz, GT; Tay, HL; Foster, PS |
